ATP synthetic capacity

1. Rapamycin decreases ATP synthetic capacity in M. cells cells.

   “Disruption of this complex following treatment with the mTOR pharmacological inhibitor rapamycin lowered mitochondrial membrane potential, oxygen consumption, and ATP synthetic capacity.”

   Cellsin mammalian cells

   The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity

   The Journal of biological chemistry·17 Jul 2006

More on Rapamycin